| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/22/2008 | US20080118494 Transgenic lymphocyte for use as model to screen viral activating and inhibitory agenys; viricides and vaccines |
| 05/22/2008 | US20080118492 Treating inflammatory disorders via oral administration of protease |
| 05/22/2008 | US20080118481 Mononuclear phagocytes in therapeutic drug delivery |
| 05/22/2008 | US20080118468 Novel Salmonella Bacteriophage and Uses Thereof |
| 05/22/2008 | US20080118464 For diagnosis, genetic engineering; post-translation modification |
| 05/22/2008 | US20080118463 Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof |
| 05/22/2008 | US20080118459 Eraser composition for de-flakes |
| 05/22/2008 | US20080118456 Aqueous composition for hair; applied onto wet or dry hair and styled without rinsing the composition off; petrolatum, ozokerit, carnauba wax, paraffin, lanolin wax; wheat, rice, potato, corn starches; anionic, cationic, non-ionic, amphoteric surfactants; polymers; UV filter; polyol; direct dye |
| 05/22/2008 | US20080118440 Reporter conjugate for non-invasive imaging of gene expression in vivo; targeting nucleic acid linked to contrast agent, iron oxide nanoparticle paramagnetic label for magnetic resonance imaging; anti-sense strand hybridizes to portion of messenger RNA encoded by expression gene to be imaged |
| 05/22/2008 | US20080118438 Loss of function mutations in calcium channel polypeptides associated with sudden cardiac death |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2669524A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | CA2669523A1 Aptamer against midkine and use thereof |
| 05/22/2008 | CA2669123A1 Acat inhibitors and their use in the prevention or treatment of fibrosis |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2666837A1 Arylsulfonamide compounds |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1923060A1 Combinations of a sphingolipid and an HMG-CoA reductase inhibitor for treating hypercholesterolemia |
| 05/21/2008 | EP1922312A1 Thiazole compounds and their use as pgd2 antagonists |
| 05/21/2008 | EP1727552B1 Tissue repair with multipotent cells |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/21/2008 | EP1517705B1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/21/2008 | EP1372652B1 Combination of docetaxel and flavopiridol |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1326838B1 Novel crystalline forms of a factor xa inhibitor |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP1150714B1 Methods for inhibiting brain tumor growth |
| 05/21/2008 | EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 05/21/2008 | EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/21/2008 | EP0781138B1 Lipid analogs for treating viral infections |
| 05/21/2008 | CN101181628A Application of human affinity prime in the preparation of anti-cancer medicament |
| 05/21/2008 | CN101181579A Chrysanthemum row containing natural aromatic plant |
| 05/21/2008 | CN101181578A Rose strip containing natural aromatic plant |
| 05/21/2008 | CN101181577A Lavender strip containing natural aromatic plant |
| 05/21/2008 | CN101181539A New use of chinese medicine composition |
| 05/21/2008 | CN101181536A Chinese medicine for curing multiple pumping symptoms |
| 05/21/2008 | CN101181363A Ginseng rhubarb injection and preparation method thereof |
| 05/21/2008 | CN101181351A Chinese medicine composition for resisting tiredness and reinforcing immune as well as method of making the same |
| 05/21/2008 | CN101181298A Chinese medicine electuary for curing animal tumescence and preparation method thereof |
| 05/21/2008 | CN101181290A Pharmaceutical composition and preparation method thereof |
| 05/21/2008 | CN101181269A Methods of treating cancer using an fpt inhibitor and antineoplastic agents |
| 05/21/2008 | CN101181263A Treatment of respiratory diseases |
| 05/21/2008 | CN100389120C Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100388951C Dietetic food composition and dietetic method using such composition |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375189 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/20/2008 | US7375121 Chemical compounds |
| 05/20/2008 | US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375115 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375106 Analgesic; Ketorolac or indomethacin nsaid with an opioid diarylmethyl piperazine such as 3-[( alpha R)- alpha -((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl]-N-(3-fluorophenyl)-N-methylbenzamide; dosage of the opioid can be decreased so side effects are reduced |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7375087 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 05/20/2008 | US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/20/2008 | US7374937 in vitro methods of inducing proliferation of stromal cells without inducing differentiation of mesenchymal stem cells; use in gene therapy and transplantation; initial density of isolated cells is less than 50 cells per sq cm of growth surface, incubating; contacting cells with antibody to Lipocortin II |
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374770 Topical applying decarboxylase inhibitor |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | CA2469833C Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2416976C Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2385440C 5-hydroxysapogenin derivatives with anti-dementia activity |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/20/2008 | CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/20/2008 | CA2294480C Microdose therapy of female sexual dysfunction by no, co, and their donors |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/20/2008 | CA2269089C Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 05/20/2008 | CA2268886C Aminothiophenecarboxamides |
| 05/20/2008 | CA2223510C Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2169621C Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 05/20/2008 | CA2159610C Prodrugs with enhanced penetration into cells |
| 05/15/2008 | WO2008057933A2 Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |